Search

ISSN 0145-2126

1. "BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION": NEITHER BURKITT-LYMPHOMA NOR DIFFUSE LARGE B-CELL LYMPHOMA. WHAT THE MICROENVIRONMENT TELLS US. (October 2022)

Authors:
Del Corvo, M.; Sapienza, M.; Siciliano, M.; Tornambè, S.; Mazzara, S.; Granai, M.; Mundo, L.; Arcuri, F.; Mancini, V.; Ferrara, D.; Ott, G.; Siebert, Reiner; Fend, L. Quintanilla; Fend, F.; Pileri, S.; Lazzi, S.; Leoncini, L.
Journal:
Leukemia research
Issue:
Volume 121(2022)Supplement
Page Start:
S46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. "Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese". Issue 3 (March 2015)

Authors:
Mele, G.; Melpignano, A.; Quarta, G.; Palumbo, G.; Capalbo, S.; Falcone, A.; Cascavilla, N.; Palazzo, G.; Mazza, P.; Iannitto, E.; Curci, P.; Rizzi, R.; Specchia, G.; Rossini, B.; Pavone, V.; Ria, R.; Vacca, A.; Buquicchio, C.; Tarantini, G.; Minoia, C.
Journal:
Leukemia research
Issue:
Volume 39:Issue 3(2015:Mar.)
Page Start:
279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 100 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH IPSS INTERMEDIATE-1 MYELODYSPLASTIC SYNDROMES WITH RBC-TRANSFUSION-DEPENDENT ANEMIA AND THROMBOCYTOPENIA: THE QUAZAR LOWER-RISK MDS TRIAL. Issue 1 (April 2015)

Authors:
Garcia-Manero, G.; Platzbecker, U.; Santini, V.; Voso, M.T.; Garcia, R.; Valcarcel, D.; Silverman, L.R.; Almeida, A.; Giagounidis, A.; Larsen, S.R.; Kreitz, S.; Hoenekopp, A.; Skikne, B.S.
Journal:
Leukemia research
Issue:
Volume 39:Issue 1(2015:Jan.)
Page Start:
S51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗